A recent study urges investment in combating Asia's antimicrobial resistance, vital for saving lives and reducing massive healthcare and socio-economic burdens. A new report compiled by leading philanthropic organisations has called for collective action and cross-sector investment to combat Asia’s growing antimicrobial resistance (AMR) threat. The study, Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia,  was compiled by the Centre for Impact Investing and Practices and the World Economic Forum’s Giving to Amplify Earth Action initiative with support from the Philanthropy Asia Alliance. “Antimicrobial resistance (AMR) is not just a looming health crisis – it is already a deadly reality, demanding urgent and coordinated global action,” said the report released in May. “Asia faces a huge challenge from the AMR crisis, accounting for more than half of the 4.71 million deaths worldwide associated with AMR in 2021. Asia’s share is by far the largest as a region.”  The study said the number of lives lost every year to AMR-related diseases is expected to reach 2.4 million in South Asia and 1.94 million in Southeast Asia, East Asia and Oceania by 2050. ...